Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout
Clinical trial NCT07752810 · COMPLETED
Trial details
- NCT number
- NCT07752810
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2024-12-06
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.